Role of hydrogen sulphide in physiological and pathological angiogenesis
Cell Proliferation · 2023-03 · 56 (3)
DOI: 10.1111/cpr.13374 ↗At a glance
Übersichtsarbeit in Cell Proliferation, published online on 2022-12-07. Written by Yan-Xia Zhang and 8 co-authors. Institution: Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, Henan University, Kaifeng, Henan, China. Major MEDLINE topics: Hydrogen Sulfide. Cited 71 times so far (Crossref); 197 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Training Program for Young Backbone Teachers of Institutions of Higher Learning in Henan Province, China, Foundation of Science & Technology Department of Henan Province, China.
Abstract (original language)
The role of hydrogen sulphide (H 2 S) in angiogenesis has been widely demonstrated. Vascular endothelial growth factor (VEGF) plays an important role in H 2 S‐induced angiogenesis. H 2 S promotes angiogenesis by upregulating VEGF via pro‐angiogenic signal transduction. The involved signalling pathways include the mitogen‐activated protein kinase pathway, phosphoinositide‐3 kinase pathway, nitric oxide (NO) synthase/NO pathway, signal transducer and activator of transcription 3 (STAT3) pathway, and adenosine triphosphate (ATP)‐sensitive potassium (K ATP ) channels. H 2 S has been shown to contribute to tumour angiogenesis, diabetic wound healing, angiogenesis in cardiac and cerebral ischaemic tissues, and physiological angiogenesis during the menstrual cycle and pregnancy. Furthermore, H 2 S can exert an anti‐angiogenic effect by inactivating Wnt/β‐catenin signalling or blocking the STAT3 pathway in tumours. Therefore, H 2 S plays a double‐edged sword role in the process of angiogenesis. The regulation of H 2 S production is a promising therapeutic approach for angiogenesis‐associated diseases. Novel H 2 S donors and/or inhibitors can be developed in the treatment of angiogenesis‐dependent diseases.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, Henan University, Kaifeng, Henan, China.
- Kaifeng Municipal Key Laboratory of Cell Signal Transduction, Henan Provincial Engineering Centre for Tumor Molecular Medicine, Henan University, Kaifeng, Henan, China.
- School of Stomatology, Henan University, Kaifeng, Henan, China.
- Kaifeng Key Laboratory of Infection and Biological Safety, School of Basic Medical Sciences, Henan University, Kaifeng, Henan, China.
ORCID profiles: Yan-Xia Zhang, Dong-Dong Wu
Funding
- National Natural Science Foundation of China
- Training Program for Young Backbone Teachers of Institutions of Higher Learning in Henan Province, China
- Foundation of Science & Technology Department of Henan Province, China
Cite
APA
Zhang, Y. X., Jing, M. R., Cai, C. B., Zhu, S. G., Zhang, C. J., Wang, Q. M., Zhai, Y. K., Ji, X. Y., & Wu, D. D. (2023). Role of hydrogen sulphide in physiological and pathological angiogenesis. Cell Proliferation, 56(3). https://doi.org/10.1111/cpr.13374
Vancouver
Zhang YX, Jing MR, Cai CB, Zhu SG, Zhang CJ, Wang QM, et al. Role of hydrogen sulphide in physiological and pathological angiogenesis. Cell Proliferation. 2023;56(3). doi:10.1111/cpr.13374
BibTeX
@article{Zhang2023,
author = {Zhang, Yan-Xia and Jing, Mi-Rong and Cai, Chun-Bo and Zhu, Shuai-Gang and Zhang, Chao-Jing and Wang, Qi-Meng and Zhai, Yuan-Kun and Ji, Xin-Ying and Wu, Dong-Dong},
title = {Role of hydrogen sulphide in physiological and pathological angiogenesis},
journal = {Cell Proliferation},
year = {2023},
volume = {56},
number = {3},
doi = {10.1111/cpr.13374}
}
EUVIMED